Welcome to MS Views and News blog

MS Views and News, empowers those affected by Multiple Sclerosis (MS) with educational information, resources and services. Please scroll downward to find articles or videos of interest, then click to open the document or video.

Categories

Latest Blog Posts

April 5, 2011

Avanir Pharmaceuticals Announces Filing of IND for AVP-923 for the Treatment of Central Neuropathic Pain in Patients with Multiple Sclerosis

  • MS Drug Therapies
    /
  • MS Research Study and Reports
    /
400-Patient International Phase 2 Clinical Trial to Begin in 2011 ALISO VIEJO, Calif., April 4, 2011 /PRNewswire/ — Avanir Pharmaceuticals, Inc. (NASDAQ: AVNR) today announced…
MS Drug Therapies

April 5, 2011

Gilenya Update

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
written by: Cherie C. Binns RN BS MSCN April 4, 2011 I attended a patient education program on Gilenya today presented…
MS Drug Therapies

April 5, 2011

Small, Uncontrolled Study Looks at Long-Term Effects of Bone Marrow Stem Cell Transplantation for MS

  • MS Research Study and Reports
    /
  • Multiple Sclerosis
    /
  • Stem Cell Related
    /
In a small uncontrolled study, 35 people with MS underwent bone marrow stem cell transplantation aimed at “rebooting” the immune…
MS Research Study and Reports

April 3, 2011

An MS Patient’s determination has helped him to “Take Steps” again…

  • An MS Patients Story
    /
  • Multiple Sclerosis
    /
Published by Stuart on 4-3-11 Jarod’s Profile: MS diagnosis 1986 No MS drugs since 2007 Organic vegetarian since 2009 walking…
An MS Patients Story

April 3, 2011

THREE varying MS Patient Stories

  • An MS Patients Story
    /
Jaxson de Ville Travels to Seattle to Help Fellow NFL Mascot First Coast News Curtis Dvorak, the man who has…
An MS Patients Story

March 30, 2011

Neurologists Anticipate Increased Use of Novartis’ Gilenya and Biogen Idec’s Tysabri over the Next Six Months Despite Safety Concerns Surrounding Both Products

  • MS Drug Therapies
    /
  • Multiple Sclerosis
    /
  • Oral MS Medications
    /
  • Tysabri
    /
March 30, 2011 EXTON, Pa.–(BUSINESS WIRE)–Physician trial and market share of Novartis’ Gilenya, the first oral disease modifying agent (DMA)…
MS Drug Therapies

March 30, 2011

Stem Cells From Placentas Show Potential in Treating Heart Disease, Multiple Sclerosis, and More

  • Multiple Sclerosis
    /
  • Stem Cell Related
    /
BY NEAL UNGERLEIDERTue Mar 29, 2011 An Israeli biotechnology firm is betting that stem cells harvested from human placentas can help…
Multiple Sclerosis

March 29, 2011

Potential New Treatment for Multiple Sclerosis

  • MS Research Study and Reports
    /
RedOrbit.com Posted on: Tuesday, 29 March 2011,  (Ivanhoe Newswire) – Multiple Sclerosis (MS) is a common, and usually disabling autoimmune…
MS Research Study and Reports

March 29, 2011

Report Identifies Cluster areas for MS in Ohio

  • MS Research Study and Reports
    /
Wellington has been designated as a disease cluster area for multiple sclerosis, according to a report released yesterday by the…
MS Research Study and Reports

March 29, 2011

The ‘MS Views & News’ – Online Charity Auction Series

  • Misc. MS Related
    /
  • Stu's Views and MS News
    /
March 29. 2011 Dear Friends, As you know, MS Views and News, Inc. is dedicated to the global collection and…
Misc. MS Related

Categories

Latest Blog Posts